Aggressive cutaneous malignancies following cardiothoracic transplantation

The development of malignancies in recipients of a cardiothoracic transplant (CTT)—that is, heart, lung, or heart and lung recipients—is of concern. Cutaneous and lymphoproliferative malignancies comprise the two major groups of malignancies encountered. A small subgroup of patients will develop potentially life‐threatening aggressive cutaneous malignancies (ACM); these are poorly defined and documented in the literature. The authors report the results for 619 CTT recipients from a single institution.

[1]  I. Penn,et al.  Cancers in cyclosporine-treated vs azathioprine-treated patients. , 1996, Transplantation proceedings.

[2]  E. Will,et al.  Risk of neoplasia in renal transplant patients , 1995, The Lancet.

[3]  Jean Kanitakis,et al.  Aggressive squamous cell carcinomas in organ transplant recipients. , 1995, Transplantation proceedings.

[4]  H. Smits,et al.  Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients , 1995, Journal of clinical microbiology.

[5]  P. Fitzgerald,et al.  Cutaneous malignant melanoma in Australia, 1989 , 1994, The Medical journal of Australia.

[6]  Y. Chardonnet,et al.  Detection of mucosal human papillomavirus types 6/11 in cutaneous lesions from transplant recipients. , 1993, The Journal of investigative dermatology.

[7]  I. Penn.  Tumors after renal and cardiac transplantation. , 1993, Hematology/oncology clinics of North America.

[8]  R. Marks,et al.  Trends in non‐melanocytic skin cancer treated in Australia: The second national survey , 1993, International journal of cancer.

[9]  A. Sheil,et al.  De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. , 1993, Transplantation proceedings.

[10]  A. Sheil.  Development of malignancy following renal transplantation in Australia and New Zealand. , 1992, Transplantation proceedings.

[11]  P. Macdonald,et al.  Initial steroid-free versus steroid-based maintenance therapy and steroid withdrawal after heart transplantation: two views of the steroid question. , 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  J. Vandenbroucke,et al.  Incidence of skin cancer after renal transplantation in The Netherlands. , 1990, Transplantation.

[13]  E. Benton,et al.  HUMAN PAPILLOMA VIRUS INFECTION AND SKIN CANCER IN RENAL ALLOGRAFT RECIPIENTS , 1989, The Lancet.

[14]  R. MacKie,et al.  CANCER, WARTS, AND SUNSHINE IN RENAL TRANSPLANT PATIENTS A Case-control Study , 1984, The Lancet.

[15]  E. Mimnaugh,et al.  Activation of pharmacologic agents to radical intermediates. Implications for the role of free radicals in drug action and toxicity. , 1982, Biochemical pharmacology.

[16]  T. Starzl,et al.  Malignant lymphomas in transplantation patients. , 1969, Transplantation proceedings.

[17]  P. Macdonald,et al.  Skin cancer in Australian heart transplant recipients. , 1999, Journal of the American Academy of Dermatology.

[18]  I. Penn.  Immunosuppression―A contributory factor in lymphoma formation , 1992 .

[19]  G. Orth.  Epidermodysplasia verruciformis: a model for understanding the oncogenicity of human papillomaviruses. , 1986, Ciba Foundation symposium.